« Previous
Next »
American Heart Journal
Volume 160, Issue 1
, Pages 49-57.e1
, July 2010
The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease—study design and objectives
References
- . A closer look at the economic argument for disease prevention. JAMA. 2009;301:536–538
- Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2002;106:3143–3421Available at: www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239Available at: www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.pdf
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952
- . Primary prevention of atherosclerotic cardiovascular disease: the high public burden of low individual risk. JAMA. 2007;297:1376–1378
- C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes. 2008;1:92–97
- C-reactive protein and parental history improve global cardiovascular risk prediction. The Reynolds Risk Score for men. Circulation. 2008;118:2243–2251
- Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–619
- Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2009;38:217–231
- Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004;25:1077–1082
- Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345
- Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49–57
- Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med. 2008;5:280–288
- . Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451:953–957
- Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005;46:1209–1218
- The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology. 2007;244:64–77
- Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–2711
- Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871–881
- . A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326:1419–1424
- U.S. Census Bureau. 2000 Census of population and housing, demographic profile. Profiles of general demographic characteristics.
- Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol. 2004;160:1152–1158
- Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf. 2008;17:842–852
- . A direct approach to false discovery rates. J R Stat Soc B. 2002;64:479–498
- . Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109–2123
- Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172
Clinical trial registration: http://www.clinicaltrials.gov/ct2/show/NCT00738725?term = bioimage&rank=1.
PII: S0002-8703(10)00165-1
doi: 10.1016/j.ahj.2010.02.021
© 2010 Mosby, Inc. All rights reserved.
« Previous
Next »
American Heart Journal
Volume 160, Issue 1
, Pages 49-57.e1
, July 2010
